The Competition Commission of India (CCI) has invited comments from the stake holders and general public on the merger of Ranbaxy Laboratories Ltd with Sun Pharmaceuticals Ltd. Sun Pharmaceuticals had entered into an agreement in Apr ... 4 Traders, 2 weeks ago
COMPETITION PANEL INVITES PUBLIC COMMENTS ON SUN-RANBAXY DEAL - TMC Net, 2 weeks ago
Anti-cancer compounds, immunogens against H1N1, cheap recombinant human insulin, stem cell research - the Indian biotech industry is in the thick of it all. Though bubbling with innovative ideas, a large number of small biotech companies and ...Pharma Letter, 1 week ago
This page uses frames, but your browser doesn'tCapital Market, 2 weeks ago Zenotech Laboratories Ltd Fixes Book Closure for 25th AGM Equity Bulls, 2 weeks ago Zenotech Laboratories to hold board meeting Capital Market, 1 month ago
Form IV contained in Schedule II to the Combination Regulations under Sec 29(2) of Competition Act, 2002 (as amended)
I. The Competition Commission of India ("Commission") is investigating the combination between Sun Pharmaceutical Industries Limited ("Sun") having its registered office at SPARC, Tandalja, Vadodra - 390 020, Gujarat, India and Ranbaxy Laboratories ...Noodls, 2 weeks ago
Hyderabad as joint capital of the two states Telangana and Andhra Pradesh, continues to attract massive investments in the manufacturing sector. According to Nirav Kothary, Head - Industrial Services, of consultancy company Jones Lang Lasalle ...Hindu Business Line, 1 month ago
on your WebpageAdd Widget >Get your members hooked!